Literature DB >> 19397411

How to design effective vaccines: lessons from an old success story.

Nabil Ahmed1, Stephen Gottschalk.   

Abstract

Evaluation of: Gaucher D, Therrien R, Kettaf N et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205(13), 3119-3131 (2008). Despite the successful development of vaccines that are able to elicit potent and protective immune responses, the majority of vaccines were developed empirically and the mechanistic events leading to protective immune responses are often poorly understood. This impedes the development of new prophylactic as well as therapeutic vaccines for infectious diseases and cancer. Gaucher et al. took advantage of the effective yellow fever vaccine 17D to prospectively identify key immunological responses elicited by the vaccine using functional genomics and flow cytometric analysis. The results of the study clearly indicate 'that the immune response to a strong vaccine is preceded by the coordinated induction of master transcription factors that lead to the development of a broad, polyfunctional and persistent immune response integrating all effector cells of the immune system'.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397411      PMCID: PMC3140531          DOI: 10.1586/erv.09.26

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  22 in total

Review 1.  Can successful vaccines teach us how to induce efficient protective immune responses?

Authors:  Paul-Henri Lambert; Margaret Liu; Claire-Anne Siegrist
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

Review 2.  On the design of national vaccination programmes.

Authors:  B A M van der Zeijst; M I Dijkman; W Luytjes; A J W van Alphen; G P J M van den Dobbelsteen
Journal:  Vaccine       Date:  2007-01-29       Impact factor: 3.641

Review 3.  Vaccines: correlates of vaccine-induced immunity.

Authors:  Stanley A Plotkin
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

4.  A framework for assessing immunological correlates of protection in vaccine trials.

Authors:  Li Qin; Peter B Gilbert; Lawrence Corey; M Juliana McElrath; Steven G Self
Journal:  J Infect Dis       Date:  2007-10-02       Impact factor: 5.226

Review 5.  Immunity and immunological memory following smallpox vaccination.

Authors:  Ian J Amanna; Mark K Slifka; Shane Crotty
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

6.  Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.

Authors:  Victor C Huber; Raelene M McKeon; Martha N Brackin; Laura A Miller; Rachael Keating; Scott A Brown; Natalia Makarova; Daniel R Perez; Gene H Macdonald; Jonathan A McCullers
Journal:  Clin Vaccine Immunol       Date:  2006-09

7.  CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.

Authors:  Elizabeth M Sitati; Michael S Diamond
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

Review 8.  Rotaviruses and rotavirus vaccines.

Authors:  Ulrich Desselberger; Emily Manktelow; Wilson Li; Winsome Cheung; Miren Iturriza-Gómara; Jim Gray
Journal:  Br Med Bull       Date:  2009-02-20       Impact factor: 4.291

9.  Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Authors:  George R Siber; Ih Chang; Sherryl Baker; Philip Fernsten; Katherine L O'Brien; Mathuram Santosham; Keith P Klugman; Shabir A Madhi; Peter Paradiso; Robert Kohberger
Journal:  Vaccine       Date:  2007-02-21       Impact factor: 3.641

10.  Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines.

Authors:  Philippe A Denoël; David Goldblatt; Isabel de Vleeschauwer; Jeanne-Marie Jacquet; Michael E Pichichero; Jan T Poolman
Journal:  Clin Vaccine Immunol       Date:  2007-08-15
View more
  8 in total

1.  Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.

Authors:  Xin Li; Jun Liu; Jianxun Qi; Feng Gao; Qirun Li; Xiaoying Li; Nianzhi Zhang; Chun Xia; George F Gao
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

2.  Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.

Authors:  Joshua O Sestak; Amir Fakhari; Ahmed H Badawi; Teruna J Siahaan; Cory Berkland
Journal:  AAPS J       Date:  2014-09-06       Impact factor: 4.009

3.  A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.

Authors:  Charani Ranasinghe; Fiona Eyers; John Stambas; David B Boyle; Ian A Ramshaw; Alistair J Ramsay
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

4.  Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation.

Authors:  Joshua T Mattila; Collin R Diedrich; Philana Ling Lin; Jiayao Phuah; JoAnne L Flynn
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

5.  Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis.

Authors:  Joshua O Sestak; Bradley P Sullivan; Sharadvi Thati; Laura Northrup; Brittany Hartwell; Lorena Antunez; M Laird Forrest; Charlotte M Vines; Teruna J Siahaan; Cory Berkland
Journal:  Mol Ther Methods Clin Dev       Date:  2014-04-09       Impact factor: 6.698

6.  A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection.

Authors:  Jin Huk Choi; Kristina Jonsson-Schmunk; Xiangguo Qiu; Devon J Shedlock; Jim Strong; Jason X Xu; Kelly L Michie; Jonathan Audet; Lisa Fernando; Mark J Myers; David Weiner; Irnela Bajrovic; Lilian Q Tran; Gary Wong; Alexander Bello; Gary P Kobinger; Stephen C Schafer; Maria A Croyle
Journal:  Mol Pharm       Date:  2014-11-14       Impact factor: 4.939

Review 7.  Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases.

Authors:  Soo Jin Oh; Young Ki Choi; Ok Sarah Shin
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

Review 8.  The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing.

Authors:  Parichehr Hassanzadeh
Journal:  Life Sci       Date:  2021-03-04       Impact factor: 6.780

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.